  Cancer cells have the plasticity to adjust their metabolic phenotypes for
survival and metastasis. During metastasis, a developmental program known as
the epithelial-mesenchymal transition (EMT) plays a critical role. There is
extensive cross-talk between metabolism and EMT, but how this leads to
coordinated physiological changes is still uncertain. The elusive connection
between metabolism and EMT compromises the efficacy of metabolic therapies
targeting metastasis. In this review, we aim for clarifying causation between
metabolism and EMT based on recent experimental studies and propose integrated
theoretical-experimental efforts to better understand the coupled
decision-making of metabolism and EMT.
